Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/25 19:06 | 2/27/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Kaneko Yasunori | CA | D | P | 201 | 10.06 | 0 | 20 | 2 | 939 | D | |||||||||||||||
2/27/25 19:05 | 2/27/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Rosen Terry J | CA | DO | CEO | P | 201 | 10.18 | 0 | 20 | 1 | 2,554 | D | ||||||||||||||
2/20/25 19:42 | 2/18/25 | RCUS | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 15,000 | 11.00 | 0 | 1,364 | 5 | 31,425 | D | |||||||||||||||
1/31/24 17:00 | 1/29/24 | RCUS | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 320,000 | 21.00 | 0 | 15,238 | 103 | 30,061 | D | |||||||||||||||
6/30/23 15:12 | 6/28/23 | RCUS | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P | 19,453 | 19.26 | 0 | 1,010 | 7 | 14,823 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |